Recruiting Parkinsons Disease Studies in Atlanta
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson'...
Cortical Electrophysiology of Response Inhibition in Parkinson's Disease
Patients with Parkinson's Disease will be studied before, during, and after a deep brain stimulation implantation procedure to see if the stimulation location and the size of the electrical field prod...
About Parkinsons Disease Clinical Trials in Atlanta
Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.
There are currently 2 parkinsons disease clinical trials recruiting participants in Atlanta, GEORGIA. These studies are seeking a combined 167 participants. Research is being sponsored by AskBio Inc, Emory University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Parkinsons Disease Clinical Trials in Atlanta — FAQ
Are there parkinsons disease clinical trials in Atlanta?
Yes, there are 2 parkinsons disease clinical trials currently recruiting in Atlanta, GEORGIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Atlanta?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.
Are clinical trials in Atlanta free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.
What parkinsons disease treatments are being tested?
The 2 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.
Data updated March 2, 2026 from ClinicalTrials.gov